Becoming a strong regional player and the first partnering choice
Expanding the product portfolio will strenghten the growth potential.
Grow organically in selected new markets to become a strong regional player with stable, geographically diversified revenues by:
Maintain the Company’s position as a leading Bulgarian pharmaceutical manufacturer with high quality affordable products and improve existing products.
During the reporting period, a marketing authorization was obtained for one new medicinal product: - Carsil 22.5 mg. coated tablets (Belarus).
Further consolidate and integrate the Group to optimize its cost structure, control entirely the production chain and benefit from potential synergies.